Dr. Kiran K Peddi Gastroenterologist in Hyderabad

Dr. Kiran K Peddi

Gastroenterologist, Hyderabad

MBBS, MRCP,CCST

  • 2 Hospitals

About

Dr. Kiran K Peddi is a consultant Gastroenterologist associated with Gastro International Clinic, Hyderabad
  • Languages : English, Hindi, Telugu

Specialities

  • Gastroenterology

  • Endoscopy

Procedures

  • Colonoscopy

  • Esophageal Dilatation

Expertise

  • EUS (Radial, linear and FNA)
  • ERCP
  • Double Balloon Enteroscopy
  • Colonoscopy& Polypectomies
  • EMR
  • Enteral stents
  • Variceal banding
  • Gluing of fundal varices
  • Oesophageal dilatations
  • Pyloric dilatations
  • Achalasia dilatations
  • Haemostatic techniques - Injection, Clipping, Gold probe, APC
  • PEG insertions
  • NJ tube placements

Education

  • MBBS from Kakatiya Medical College, Warangal
  • MRCP (UK), CCST(Gastro), PGDM Gastro (Salford Uni, UK), Fellowship in Interventional Endoscopy and IBD (Aus)

Practice Information

Gastro International Clinic, Hyderabad

Gastro International Clinic, Hyderabad

313, Ayyappa Society Main Road, Ayyappa Society, Mega Hills, Madhapur, Hyderabad, Telangana - 500081

Citizens Hospital, Hyderabad

Citizens Hospital, Hyderabad

Nallagandla, Serilingampally, Hyderabad, Telangana - 500019

Achievements & Contributions

  • 200-A multi centre double blind randomised placebo controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis- Acting as the Principal co -investigator - writing up Protocol
  • Sub investigator for the following clinical trials
  • 2009-The Risk of skin cancer development in Inflammatory Bowel Disease Patients on Azathioprine/6-Mercaptopurine
  • 2009-Psycho-sexual function, Fertility and Sperm Integrity in Men with IBD
  • 2008-A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicentre Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients with Moderate to Severe Ulcerative Colitis. Protocol C13006
  •  2008-A Phase 3, Randomized, Placebo-Controlled, Blinded, Multicentre Study of the Induction and Maintenance of Clinical Response and Remission by MLN0002 in Patients with Moderate to Severe Crohn's Disease. Protocol C13007
  • 2008-A Phase 3, Open-label Study to Determine the Long-Term Safety and Efficacy of MLN0002 in Patients with Ulcerative Colitis and Crohn's Disease. Protocol C13008
  • 2008-A Phase III, randomised, multi-centre, double-blind, parallel group, active comparator study to compare the efficacy and safety of SPD476 (mesalazine) 2.4g/day once daily (QD) with Asacol® 1.6g/day twice daily (BID) in the maintenance of remission in patients with ulcerative colitis. Protocol SPD476-304
  • 2008-Study Title: A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 versus Placebo over 104 weeks in the Prevention of Recurrence of Diverticulitis. Protocol number: SPD476-313
  • 2008-A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Moderately to Severely Active Ulcerative Colitis. Protocol No. M06-827
  • 2008-A 5-Year, Registry Study of HUMIRA® (Adalimumab) in Patients With Moderately to Severely Active Crohn's Disease (CD). Protocol No.: P06-134
  • 2008-A phase IIIb, multinational, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of certolizumab pegol, a pegylated Fab' fragment of a humanized anti-TNF-alpha monoclonal antibody, administered subcutaneously at weeks 0, 2 and 4 in subjects with moderately to severely active Crohn's disease. Protocol No.: C87085
  • 2008-A phase IIIb, multinational, open-label, follow-on trial to C87085 designed to assess the long-term safety of certolizumab pegol, a pegylated Fab' fragment of a humanized anti TNF alpha monoclonal antibody, administered at weeks 0, 2 and 4, and then every 4 weeks thereafter, in subjects with moderately to severely active Crohn's disease who have participated in study C87085. Protocol No: C87088
  • 2007-A Phase lll, Multicentre, Randomised, Placebo-Controlled, Study to Evaluate the Clinical Efficacy and Safety of Induction and Maintenance Therapy with Abatacept in Subjects with Active Crohn's Disease (CD) Who Have Had Inadequate Clinical Response and/or Intolerance to Medical Therapy. Protocol No.IM101-084
  • 2007-A Phase lll, Multicentre, Randomised, Placebo-Controlled, Withdrawal Study to Evaluate the Clinical Efficacy and Safety of Maintenance Therapy with Abatacept in Subjects with Active Ulcerative Colitis (UC) Who Have Had Inadequate Clinical Response and/or Intolerance to Medical Therapy. Protocol No.IM101-108
  • 2008-Protocol CDP870-034: A Phase III multi-national, multi-centre, open label, 52 week safety study to assess the safety of re-exposure after a variable interval and subsequent chronic therapy with humanised anti-TNF PEG conjugated CDP870 400mg sc, (dosed at weeks 0,2 and 4 then 4-weekly to Week 48), in the treatment of patients with active Crohn's disease who have previously been withdrawn from studies CDP870-031 or CDP870-032 due to an exacerbation of Crohn's disease
  • A randomized double blind , placebo controlled study of VSL#3 versus placebo in maintenance of remission in Crohns disease - KK Peddi et al. Journal of Gastroenterology and Hepatology 2009; 24 (suppl.2) A 317
  • Precut Sphincterotomy - is it worth the risk? - KK Peddi, DF Martin: Accepted for poster presentation at BSG 2008. Abstract no 250 in GUT March 2008,Vol57, suppl 1
  • Needle knife papillotomy in expert hands - Is it safe and effective? KK Peddi, DF Martin: Abstract in Gastrointestinal Endoscopy (GIE) - Vol 65, Number 5, April 2007 (Page AB218) and poster at DDW, Washington DC 2007
  • Experience with Endoclips in acute GI bleeds in a tertiary center: F.Mohammed, KK Peddi, C Babbs: Abstract in GUT, Poster presentation at BSG 2007
  • Muscle cramps in patients on Home parenteral Nutrition: Is there a predictable pattern? KK Peddi, F Mohammed, J Shaffer - GUT Supplement Nov Vol 55, page A180. Presented as a poster in UEGW, Berlin, October 2006
  • An interesting case of Jaundice with multisystem involvement; KK Peddi, D O'Riordan - GUT, April 2006, Supplement no.11, Vol 55, page A 32, case no.120. Electronic case presentation BSG, Birmingham, March 2006
  • The Value of 24 hr Blood Pressure Monitoring in Geriatric Population; KK Peddi, T Shawis - Journal of the American Geriatrics Society, April 2001 Number 4, 349 - 504; Abstract Number P154. Presented as a poster at American Geriatric Society annual conference, Chicago, 2001
  • TEXT BOOK CHAPTERSHow does the risk of infection influence management of IBD across the world KK Peddi, IC Lawrance - in the process of submitting to More clinical dilemmas in IBD (Blackwell publishers).
  • Submitted 4 chapters (Acute Pancreatitis, Nonvariceal Haemorrhage, Variceal Haemorrhage, Acute Dysphagia) as the first author to Gastrointestinal Emergencies section of Davidson's Acute Medicine companion (Due to come out in 2010)

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Kiran K Peddi and his staff know how they are doing and how they can improve their services.